Hengrui Pharma Showcases Global Impact at the 2025 ASCO: 72 Study Results Highlight Chinese Cancer Innovation ...Middle East

SHANGHAI, June 5, 2025 /PRNewswire/ -- The 2025 ASCO Annual Meeting successfully concluded in Chicago on June 3 (local time). Hengrui Pharma delivered a strong international presence, featuring 15 innovative drugs and 72 research outcomes. These included 4 oral presentations, 5 rapid oral...

Read More Details
Finally We wish PressBee provided you with enough information of ( Hengrui Pharma Showcases Global Impact at the 2025 ASCO: 72 Study Results Highlight Chinese Cancer Innovation )

Also on site :

• NYT Connections Sports Edition Today: Hints and Answers for June 6
• Beloved '90s Hitmaker, 61, Commands the Red Carpet in a Striking Look During Rare Red Carpet Appearance
• NYT ‘Connections’ Hints and Answers Today, Friday, June 6